CHONDROTISSUE Logo (USPTO, 12/22/2006)
USPTOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The US trademark CHONDROTISSUE was filed as Word and figurative mark on 12/22/2006 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 10/21/2008.
The current status of the mark is "IR CANCELLED; US REGISTRATION CANCELLED".
| Trademark form | Word and figurative mark |
| File reference | 79034419 |
| Register number | 3520741 |
| Application date | December 22, 2006 |
| Publication date | August 5, 2008 |
| Entry date | October 21, 2008 |
Trademark owner
CH-8038 Zürich
Trademark representatives
goods and services
5
Polymer-based pharmaceutical preparations for use in tissue and organ transplantation, namely, regenerative, reparative and hemostatic preparations, consisting of hyaluronic acid and bioresorbable polyglycolic acid polymers; biomedical polymer-based pharmaceutical preparations, namely, preparations for use in tissue and organ transplantation, namely regenerative, reparative and hemostatic preparations, consisting of hyaluronic acid and bioresorbable polyglycolic acid polymers
10
Medical devices in the nature of surgical implants primarily comprising artificial tissue, also consisting of biological cartilage, intervertebral disc, meniscus, tendon, ligament, bone and connective tissue substitutes intended for subsequent implantation, all sold as a unit; surgical implants primarily comprising artificial tissue, also consisting of hyaluronic acid, biological polymers, bioresorbable polymers and combinations thereof, all sold as a unit; biological surgical implants primarily comprising artificial tissue also consisting of hyaluronic acid, biological polymers, bioresorbable polymers and combinations thereof, all sold as a unit; health care products in the nature of surgical implants primarily comprising artificial tissue, also consisting of biological cartilage, intervertebral disc, meniscus, tendon, ligament, bone and connective tissue substitutes intended for subsequent implantation, all sold as a unit; products of tissue engineering, namely, surgical implants and modified surgical implants primarily comprising artificial material, also consisting of biological materials, all sold as a unit; tissue precursors, namely, surgical implants primarily comprising artificial material also consisting of molecules, namely, hyaluronic acid, biological polymers, bioresorbable polymers and combinations thereof produced in vitro for replacing and supporting the function of absent or injured body parts, all sold as a unit; artificial cartilage replacements and tissue replacements, namely, primarily artificial substitutes for bones, cartilage, ligaments, and tendons, also consisting of implants of hyaluronic acid, biological polymers, bioresorbable polymers and combinations thereof, all sold as a unit; biological replacement and biological protection of mesenchymal tissue, namely, primarily artificial substitutes for bones, cartilage, ligaments and tendons also consisting of implants of hyaluronic acid, biological polymers, bioresorbable polymers and combinations thereof, all sold as a unit
42
Research and development of pharmaceutical preparations and medicines; consultancy in the field of biomedicine
ID: 1379034419